Sartorius Aktiengesellschaft (FRA:SRT4)

Market Cap	17.41B +16.3%
Revenue (ttm)	3.66B +4.2%
Net Income	218.50M +63.5%
EPS	n/a
Shares Out	n/a
PE Ratio	79.67
Forward PE	41.95
Dividend	0.08 (0.18%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	42.60
Previous Close	41.40
Day's Range	42.60 - 42.60
52-Week Range	31.60 - 42.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About FRA:SRT4

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 14,273
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SRT4

Financial Performance

In 2025, FRA:SRT4's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 24, 2026

Data Sources Report a data error